- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Schizophrenia
- Meeting Date: July 2014
- Public Summary Document (PSD) July 2014 PBAC Meeting - PDF
- Public Summary Document (PSD) July 2014 PBAC Meeting - Word
Aripiprazole – July 2014
ARIPIPRAZOLE, 300 mg injection: modified release [1 x 300 mg vial], 400 mg injection: modified release [1 x 400 mg vial], Abilify Maintena®, Lundbeck Australia Pty Ltd
Last updated
8 November 2023